This optimized

method was able to produce smooth, spherical, stable, white colored free flowing nanoparticles. Furthermore the drug loaded nanoparticles were characterized and evaluated. The FT-IR spectra illustrated that the characteristic peaks of ddi, BSA and nanoparticles whereas the characteristic peaks of nanoparticles (Fig. 1) remain same with slight modifications due to other excipients present in the formulations. The DSC thermogram of drug and lyophilized nanoparticles are shown in Fig. 2. DSC curves showed that endothermic peak at 193.8 °C, 282.9 °C in didanosine and 77.6 °C, 193.6 °C in nanoparticles and represented the didanosine melting point. From DSC profiles, it was concluded that the didanosine was present in the formulated nanoparticles Dabrafenib datasheet in the amorphous state and might have dispersed uniformly in the polymer. % EE and % drug loading depending on the drug polymer ratio are shown in Table 1. The % EE was decreased with respect to drug polymer

mass ratio due to limited affinity of the drug molecule to the macromolecular material. In a nanocarrier system the drug loading is important to determine the amount of drug substance required for the injection. The % drug loading was found to be high to low with increase concentration of BSA due to the concentration of ddi was kept constant and was 28.34 ± 0.23 to 9.48 ± 0.83. The morphological properties and Panobinostat in vivo surface appearance of ddi loaded BSA nanoparticles has observed using scanning electron microscopy and demonstrated that nanoparticles were spherical, smooth Bay 11-7085 surface. Fig. 3a and b depicts the SEM image and particle size distribution of ddi loaded nanoparticles. The mean

particle size of ddi loaded nanoparticles were found to be ranged between 194.8 and 268 nm with polydispersity index was in the range of 0.121–0.281.The mean zeta potential was found to be −23.0 to −36.6 which indicates high degrees of stability due to inter particle repulsions and are shown in Table 2. Fig. 4 shows the comparative graph of cumulative percentage ddi release profiles from nanoparticles and was observed burst release of ddi within 1 h from nanoparticles due to the dissociation of entrapped drug close to the surface layer of nanoparticles. Later the drug release was observed the slow and sustained manner over 24 h. In D1% cumulative ddi release was found to be high due higher drug loading and lower polymer concentration than in D5 which showed % cumulative ddi release was low and also observed lesser burst effect. The drug release mechanism characterized by applying the in vitro release data to various kinetic models and results of n and r2 values of different kinetic model represent in Table 3. Diffusion controlled drug release was observed with higher r2 in Higuchi model.